cefuroxime has been researched along with methicillin in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (30.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, C; Stratton, CW; Weeks, LS | 1 |
| Gahrn-Hansen, B; Hansen-Nord, M; Siboni, K | 1 |
| Sørensen, TS | 1 |
| McColm, AA; Ryan, DM | 1 |
| Hansen, BG | 1 |
| Acred, P; McColm, AA; Ryan, DM | 1 |
| Dudzevicius, V; Sakalauskas, R; Vitkauskiene, A | 1 |
| Georgala, S; Krasagakis, K; Maniatakis, P; Samonis, G; Tosca, A | 1 |
| Appelbaum, PC; Glupczynski, Y; Lemaire, S; Olivier, A; Tulkens, PM; Van Bambeke, F | 1 |
| Corey, GR; Fowler, VG; Murray, BE; Nannini, EC; Rude, TH; Singh, KV; Stryjewski, ME | 1 |
| Akar, M; Dilmen, U; Erdeve, O; Oguz, SS; Sandal, G; Uras, N | 1 |
| Arpi, M; Benfield, T; Knudsen, JD; Ostergaard, C; Rasmussen, JB; Schønheyder, HC | 1 |
| Benfield, T; Bigseth, RS; Petersen, A; Sandholdt, H; Thorlacius-Ussing, L; Østergaard, C | 1 |
| Bonten, MJM; Buis, DTP; Herpers, BL; Jansen, RR; Prins, JM; Rozemeijer, W; Sieswerda, E; Sigaloff, KCE; Soetekouw, R; van der Meer, JTM; van der Vaart, TW; van Twillert, G; van Werkhoven, CH; Veenstra, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Collins, B; Cotter, PD; Hill, C; Joyce, S; Ross, RP | 1 |
| Bommareddy, A; Gionfriddo, MR; Heindel, GA; Mukhija, P; Vanwert, AL; Witkowski, S; Wolman, AT | 1 |
| Chan, EWC; Chan, KF; Chan, TH; Chen, S; Cheung, KC; Chiou, J; Gao, W; Jin, WB; Kan, JWY; Leung, YC; Lin, D; Lui, HK; Sun, N; Wong, ILK; Wong, KY | 1 |
20 other study(ies) available for cefuroxime and methicillin
| Article | Year |
|---|---|
Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies.
Topics: Anti-Bacterial Agents; Cefamandole; Cefazolin; Cefuroxime; Ciprofloxacin; Culture Media; Daptomycin; Kinetics; Methicillin; Microbial Sensitivity Tests; Peptides; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 1987 |
Studies on clinical isolates of coagulase-negative staphylococci resistant to methicillin. Evidence of cross-resistance between methicillin and cephalothin.
Topics: Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Cephalothin; Coagulase; Drug Resistance, Microbial; Humans; Methicillin; Staphylococcal Infections; Staphylococcus | 1988 |
Comparative in vitro activity of four beta-lactam antibiotics in surgical wound fluid against staphylococci.
Topics: Anti-Bacterial Agents; Cefuroxime; Cephalothin; Culture Media; Dicloxacillin; Hip Fractures; Humans; Methicillin; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Surgical Wound Infection | 1985 |
Penetration of beta-lactam antibiotics into cardiac vegetations, aorta and heart muscle in experimental Staphylococcus aureus endocarditis: comparison of ceftazidime, cefuroxime and methicillin.
Topics: Animals; Anti-Bacterial Agents; Body Fluids; Ceftazidime; Cefuroxime; Endocarditis, Bacterial; Female; Methicillin; Microbial Sensitivity Tests; Myocardium; Rabbits; Staphylococcal Infections | 1985 |
Population analysis in strains of Staphylococcus aureus and Staphylococcus epidermidis. II. Cefuroxime and cefotaxime.
Topics: Cefotaxime; Cefuroxime; Cephalosporins; Dose-Response Relationship, Drug; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Staphylococcus aureus; Staphylococcus epidermidis | 1983 |
Comparison of ceftazidime, cefuroxime and methicillin in the treatment of Staphylococcus aureus endocarditis in rabbits.
Topics: Animals; Ceftazidime; Cefuroxime; Cephalosporins; Endocarditis, Bacterial; Female; Methicillin; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections | 1984 |
[The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bronchoalveolar Lavage Fluid; Ceftazidime; Cefuroxime; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fusidic Acid; Gentamicins; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Staphylococcus aureus; Sulbactam; Vancomycin Resistance | 2003 |
Bullous erysipelas: clinical presentation, staphylococcal involvement and methicillin resistance.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefuroxime; Cloxacillin; Drug Therapy, Combination; Erysipelas; Female; Humans; Male; Methicillin; Methicillin Resistance; Middle Aged; Netilmicin; Penicillins; Skin; Staphylococcus; Treatment Outcome; Vancomycin | 2006 |
Restoration of susceptibility of intracellular methicillin-resistant Staphylococcus aureus to beta-lactams: comparison of strains, cells, and antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefepime; Cefuroxime; Cell Line; Cells, Cultured; Cephalosporins; Cloxacillin; Humans; Hydrogen-Ion Concentration; Imipenem; Meropenem; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Phagocytosis; Staphylococcus aureus; Thienamycins | 2008 |
Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillin-susceptible Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Cephalexin; Cephalosporins; Cephalothin; Humans; Methicillin; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 2010 |
Iliac osteomyelitis in a newborn: a case report.
Topics: Anti-Bacterial Agents; Blood; Cefuroxime; Humans; Ilium; Infant, Newborn; Methicillin; Microbial Sensitivity Tests; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2012 |
Relative efficacy of cefuroxime versus dicloxacillin as definitive antimicrobial therapy in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-score adjusted retrospective cohort study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cefuroxime; Cohort Studies; Dicloxacillin; Female; Humans; Male; Methicillin; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Propensity Score; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2014 |
Comparable Effectiveness of Cefuroxime and Piperacillin-Tazobactam as Empirical Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cefuroxime; Cohort Studies; Humans; Methicillin; Piperacillin; Recurrence; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Tazobactam; Treatment Outcome | 2022 |
Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Ceftriaxone; Cefuroxime; Floxacillin; Humans; Methicillin; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2023 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
TelA contributes to the innate resistance of Listeria monocytogenes to nisin and other cell wall-acting antibiotics.
Topics: Anti-Bacterial Agents; Bacitracin; Bacterial Proteins; Bacteriocins; Cefuroxime; Cell Wall; Drug Resistance, Multiple, Bacterial; Listeria monocytogenes; Nisin; Peptides; Tellurium | 2010 |
Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Biological Transport; Cell Line, Transformed; Humans; Mice; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Solubility; Structure-Activity Relationship | 2013 |
Boosting the efficacy of anti-MRSA β-lactam antibiotics via an easily accessible, non-cytotoxic and orally bioavailable FtsZ inhibitor.
Topics: Animals; Bacterial Proteins; beta-Lactams; Binding Sites; Cefuroxime; Cytoskeletal Proteins; Drug Synergism; Methicillin-Resistant Staphylococcus aureus; Mice; Small Molecule Libraries; Staphylococcal Infections; Staphylococcus aureus | 2019 |